mesalamine and Nephrolithiasis studies

mesalamine and Nephrolithiasis

mesalamine has been researched along with Nephrolithiasis in 3 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Nephrolithiasis: Formation of stones in the KIDNEY.

Research Excerpts

Excerpt	Relevance	Reference
"We present two cases of lithiasis in patients treated with mesalazine at high dosage, an adverse effect to betaken into account as a drug lithiasis and which is not even mentioned in the patient information leaflet."	1.56	[Mesalazine renal lithiasis.] ( Benavent, G; Frédérique Scheirs, S; Orts, JA; Vílchez, A, 2020)
"She had ulcerative colitis and had been taking salazosulfapyridine (SASP) for about 30 years."	1.51	[DRUG-INDUCED BILATERAL NEPHROLITHIASIS IN AN ULCERATIVE COLITIS PATIENT: A CASE REPORT]. ( Kurosawa, K; Nagamoto, S; Ogawa, K; Oka, S; Okaneya, T; Sakaguchi, K; Urakami, S, 2019)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (66.67)

24.3611

2020's

1 (33.33)

2.80

Authors

Authors	Studies
Ogawa, K	1
Sakaguchi, K	1
Oka, S	1
Nagamoto, S	1
Kurosawa, K	1
Urakami, S	1
Okaneya, T	1
Vílchez, A	1
Orts, JA	1
Frédérique Scheirs, S	1
Benavent, G	1
Simsek, M	1
de Boer, NKH	1

Studies

Ogawa, K

Sakaguchi, K

Oka, S

Nagamoto, S

Kurosawa, K

Urakami, S

Okaneya, T

Vílchez, A

Orts, JA

Frédérique Scheirs, S

Benavent, G

Simsek, M

de Boer, NKH

Other Studies

3 other studies available for mesalamine and Nephrolithiasis

Article	Year
[DRUG-INDUCED BILATERAL NEPHROLITHIASIS IN AN ULCERATIVE COLITIS PATIENT: A CASE REPORT]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2019, Volume: 110, Issue:1 Topics: Colitis, Ulcerative; Female; Humans; Lithotripsy; Mesalamine; Middle Aged; Nephrolithiasis; Sulfasal	2019
[Mesalazine renal lithiasis.] Archivos espanoles de urologia, 2020, Volume: 73, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Calculi; Humans; Kidney; Kidney Calculi; Lithiasis; Mesalam	2020
Mesalazine and Nephrolithiasis: Leave No Stone Unturned. The American journal of gastroenterology, 2019, Volume: 114, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Mesalamine; Nephrolith	2019

Article

Year

[DRUG-INDUCED BILATERAL NEPHROLITHIASIS IN AN ULCERATIVE COLITIS PATIENT: A CASE REPORT].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2019, Volume: 110, Issue:1

Topics: Colitis, Ulcerative; Female; Humans; Lithotripsy; Mesalamine; Middle Aged; Nephrolithiasis; Sulfasal

2019

[Mesalazine renal lithiasis.]

Archivos espanoles de urologia, 2020, Volume: 73, Issue:6

Topics: Anti-Inflammatory Agents, Non-Steroidal; Calculi; Humans; Kidney; Kidney Calculi; Lithiasis; Mesalam

2020

Mesalazine and Nephrolithiasis: Leave No Stone Unturned.

The American journal of gastroenterology, 2019, Volume: 114, Issue:8

Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Mesalamine; Nephrolith

2019